e-learning
resources
London 2016
Monday, 05.09.2016
Endosonography: EBUS/EUS (B)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Features predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound in Indian setting: Is it different?
Jeenam Shah (Mumbai, India), Jeenam Shah, Rajiv Goyal, Chetan Nemani, Kedar Hibare
Source:
International Congress 2016 – Endosonography: EBUS/EUS (B)
Session:
Endosonography: EBUS/EUS (B)
Session type:
Poster Discussion
Number:
2047
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jeenam Shah (Mumbai, India), Jeenam Shah, Rajiv Goyal, Chetan Nemani, Kedar Hibare. Features predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound in Indian setting: Is it different?. Eur Respir J 2016; 48: Suppl. 60, 2047
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Tuberculosis with mediastinal lymph node involvement: Current diagnostic techniques in clinical practice
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Isolated mediastinal lymphadenopathy - How does EBUS-TBNA perform in clinical practice?
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
EBUS-TBNA in the diagnose of intrathoracic lymph nodes of patients with extratoracic malignancy
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
EBUS-TBNA for the evaluation of isolated mediastinal and/or hilar lymphadenopathy (IMHL)
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Endobronchial ultrasound elastography type classification in the diagnosis of mediastinal and hilar lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy
Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery
Year: 2013
Ultrasonographic evaluation of mediastinal lymph nodes using endobronchial ultrasound
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
EBUS in real life: Primary diagnosis and mediastinal staging
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Diagnostic performance of EBUS-TBNA in patients with mediastinal lymphadenopathy and extrathoracic malignancy
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
Improved negative predictive value of EBUS-TBNA in isolated mediastinal / hilar lymphadenopathy: Why and what it means for patients?
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
EBUS-TBNA in sarcoidosis and lymphoma: Exploring the importance of culture on lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
The role of rapid on-site evaluation in the adequacy EBUS-TBNA specimens in the verification of mediastinal lymphadenopathy
Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions
Year: 2014
Endobronchial ultrasound elastography for the prediction of malignant intrathoracic lymph nodes during EBUS-TBNA
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
EBUS-TBNA as first step procedure for differential diagnosis of mediastinal lymphadenopathy in country with high prevalence of tuberculosis
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014
Extended possibilities of thoracoscopy at patients with mediastinal pathology
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Predictive value of pre-test clinical diagnosis for mediastinal lymphadenopathy compared to histological outcomes from cervical mediastinoscopy
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Utility of EUS-B-FNA for the diagnosis of EBUS-TBNA inaccessible intrathoracic lesions
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
Normal lymph node size at Endobronchial ultrasound guided Transbronchial needle aspiration correlates to benign cytopathological diagnosis but does not rule out malignancy
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept